{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:46:53Z","timestamp":1783032413879,"version":"3.54.6"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T00:00:00Z","timestamp":1309392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s00266-011-9771-3","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T01:54:53Z","timestamp":1309398893000},"page":"180-185","source":"Crossref","is-referenced-by-count":12,"title":["High-density Hyaluronic Acid for the Treatment of HIV-related Facial Lipoatrophy"],"prefix":"10.1007","volume":"36","author":[{"given":"Marco","family":"Pignatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pedone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Baccarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Guaraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,30]]},"reference":[{"key":"9771_CR1","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2310\/6350.2005.31237","volume":"31","author":"D Jones","year":"2005","unstructured":"Jones D (2005) HIV facial lipoatrophy: causes and treatment options. Dermatol Surg 31:1519\u20131529","journal-title":"Dermatol Surg"},{"issue":"3","key":"9771_CR2","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1468-1293.2007.00537.x","volume":"9","author":"A Nguyen","year":"2008","unstructured":"Nguyen A, Calmy A, Schiffer V, Bernasconi E, Battegay M, Opravil M, Evison JM, Tarr PE, Schmid P, Perneger T, Hirschel B, Swiss HIV Cohort Study (2008) Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000\u20132006. HIV Med 9(3):142\u2013150","journal-title":"HIV Med"},{"issue":"6","key":"9771_CR3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1468-1293.2009.00694.x","volume":"10","author":"P Benn","year":"2009","unstructured":"Benn P, Sauret-Jackson V, Cartledge J, Ruff C, Sabin CA, Moyle G, Linney A, Reilly G, Edwards SG (2009) Improvements in cheek volume in lipoatrophic individuals switching away from thymidine nucleoside reverse transcriptase inhibitors. HIV Med 10(6):351\u2013355","journal-title":"HIV Med"},{"issue":"5","key":"9771_CR4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/655765","volume":"51","author":"E Hammond","year":"2010","unstructured":"Hammond E, McKinnon E, Nolan D (2010) Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences. Clin Infect Dis 51(5):591\u2013599","journal-title":"Clin Infect Dis"},{"key":"9771_CR5","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/QAD.0b013e32833ac7a2","volume":"24","author":"C Grunfeld","year":"2010","unstructured":"Grunfeld C, Saag M, Cofrancesco J Jr, Lewis CE, Kronmal R, Heymsfield S, Tien PC, Bacchetti P, Shlipak M, Scherzer R (2010) Study of fat redistribution and metabolic change in HIV infection (FRAM). Regional adipose tissue measured by MRI over 5\u00a0years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy. AIDS 24:1717\u20131726","journal-title":"AIDS"},{"key":"9771_CR6","first-page":"369","volume":"15","author":"M Echavez","year":"2005","unstructured":"Echavez M, Horstman W (2005) Relationship between lipoatrophy and quality of life. AIDS Read 15:369\u2013375","journal-title":"AIDS Read"},{"issue":"7","key":"9771_CR7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1177\/135965350701200713","volume":"12","author":"G Guaraldi","year":"2007","unstructured":"Guaraldi G, Luzi K, Murri R, Granata A, De Paola M, Orlando G, Squillace N, Malmusi D, Carani C, Comelli D, Esposito R, Martinez E (2007) Sexual dysfunction in HIV-infected men: role of antiretroviral therapy, hypogonadism and lipodystrophy. Antivir Ther 12(7):1059\u20131065","journal-title":"Antivir Ther"},{"key":"9771_CR8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.prs.0000298108.46379.15","volume":"121","author":"G Santis De","year":"2008","unstructured":"De Santis G, Jacob V, Baccarani A, Pedone A, Pinelli M, Spaggiari A, Guaraldi G (2008) Polyacrylamide hydrogel injection in the management of human immunodeficiency virus\u2013related facial lipoatrophy: a 2-year clinical experience. Plast Reconstr Surg 121:644\u2013653","journal-title":"Plast Reconstr Surg"},{"key":"9771_CR9","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/00002030-200311210-00009","volume":"17","author":"MA Valantin","year":"2003","unstructured":"Valantin MA, Aubron-Olivier C, Ghosn J, Laglenne E, Pauchard M, Schoen H et al (2003) Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 17:2471\u20132477","journal-title":"AIDS"},{"issue":"6","key":"9771_CR10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/135965350501000606","volume":"10","author":"G Guaraldi","year":"2005","unstructured":"Guaraldi G, Orlando G, De Fazio D, De Lorenzi I, Rottino A, De Santis G, Pedone A, Spaggiari A, Baccarani A, Borghi V, Esposito R (2005) Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study. Antivir Ther 10(6):753\u2013759","journal-title":"Antivir Ther"},{"issue":"12","key":"9771_CR11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/apc.2006.20.829","volume":"20","author":"E Negredo","year":"2006","unstructured":"Negredo E, Higueras C, Adell X, Martinez JC, Martinez E, Puig J, Fumaz CR, Mu\u00f1oz-Moreno JA, Perez-Alvarez N, Videla S, Estany C, Cinquegrana D, Gonzalez-Mestre V, Clotet B (2006) Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances. AIDS Patient Care STDS 20(12):829\u2013837","journal-title":"AIDS Patient Care STDS"},{"issue":"Suppl 5","key":"9771_CR12","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1097\/PRS.0b013e31816de8d0","volume":"121","author":"JDA Carruthers","year":"2008","unstructured":"Carruthers JDA, Glogau RG, Blitzer A et al (2008) Botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies\u2013consensus recommendations. Plast Reconstr Surg 121(Suppl 5):5S\u201330S","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"9771_CR13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1529-8019.2010.01380.x","volume":"24","author":"KP Redbord","year":"2011","unstructured":"Redbord KP, Busso M, Hanke CW (2011) Soft-tissue augmentation with hyaluronic acid and calcium hydroxyl apatite fillers. Dermatol Ther 24(1):71\u201381","journal-title":"Dermatol Ther"},{"key":"9771_CR14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1524-4725.2002.01200.x","volume":"28","author":"PM Friedman","year":"2002","unstructured":"Friedman PM, Mafong EA, Kauvar AN, Geronemus RG (2002) Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 28:291\u2013294","journal-title":"Dermatol Surg"},{"issue":"2","key":"9771_CR15","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0029-1220647","volume":"25","author":"KL Beasley","year":"2009","unstructured":"Beasley KL, Weiss MA, Weiss RA (2009) Hyaluronic acid fillers: a comprehensive review. Facial Plast Surg 25(2):86\u201394","journal-title":"Facial Plast Surg"},{"key":"9771_CR16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1468-1293.2007.00494.x","volume":"8","author":"H Bugge","year":"2007","unstructured":"Bugge H, Negaard A, Skeie L, Bergersen B (2007) Hyaluronic acid treatment of facial fat atrophy in HIV-positive patients. HIV Med 8:475\u2013482","journal-title":"HIV Med"},{"key":"9771_CR17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1468-1293.2009.00761.x","volume":"11","author":"L Skeie","year":"2010","unstructured":"Skeie L, Bugge H, Negaard A, Bergersen BM (2010) Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study. HIV Med 11:170\u2013177","journal-title":"HIV Med"},{"issue":"3","key":"9771_CR18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000148252","volume":"217","author":"FG Bechara","year":"2008","unstructured":"Bechara FG, Gambichler T, Brockmeyer NH, Sand M, Altmeyer P, Hoffmann K (2008) Hyaluronic acid new formulation: experience in HIV-associated facial lipoatrophy. Dermatology 217(3):244\u2013249","journal-title":"Dermatology"},{"issue":"Suppl 2","key":"9771_CR19","first-page":"L31","volume":"12","author":"J Fontdevila","year":"2007","unstructured":"Fontdevila J, Prades E, Pujol T, Guisantes E, Serra-Renom JM, Gatell J, Mart\u00ednez E (2007) Validation of a simple classification for facial lipoatrophy in HIVinfected adults. Antivir Ther 12(Suppl 2):L31","journal-title":"Antivir Ther"},{"key":"9771_CR20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1310\/EYWJ-8B5K-X7VQ-9CPE","volume":"7","author":"G Guaraldi","year":"2006","unstructured":"Guaraldi G, Orlando G, Squillace N et al (2006) Multidisciplinary approach to the treatment of metabolic and morphologic alterations of HIV-related lipodystrophy. HIV Clin Trials 7:97\u2013106","journal-title":"HIV Clin Trials"},{"issue":"Suppl","key":"9771_CR21","doi-asserted-by":"crossref","first-page":"41S","DOI":"10.1097\/01.prs.0000248794.63898.0f","volume":"120","author":"RJ Rohrich","year":"2007","unstructured":"Rohrich RJ, Ghavami A, Crosby MA (2007) The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: review and technical considerations. Plast Reconstr Surg 120(Suppl):41S","journal-title":"Plast Reconstr Surg"},{"issue":"3 Suppl","key":"9771_CR22","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1097\/01.prs.0000234847.36020.52","volume":"118","author":"SL Silvers","year":"2006","unstructured":"Silvers SL, Eviatar JA, Echavez MI, Pappas AL (2006) Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability. Plast Reconstr Surg 118(3 Suppl):34S\u201345S","journal-title":"Plast Reconstr Surg"},{"key":"9771_CR23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1468-1293.2004.00190.x","volume":"5","author":"GJ Moyle","year":"2004","unstructured":"Moyle GJ, Lysakova L, Brown S et al (2004) A randomized open label study of immediate vs. delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med 5:82\u201397","journal-title":"HIV Med"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-011-9771-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00266-011-9771-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-011-9771-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T21:56:32Z","timestamp":1686174992000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00266-011-9771-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,30]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["9771"],"URL":"https:\/\/doi.org\/10.1007\/s00266-011-9771-3","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,30]]}}}